CTRI/2024/04/065924Not yet recruitingPhase 1
Adjunct therapy with topical Recombinant DNA Polymerase in Dry eye disease - NI
Dr RP Centre Of Ophthalmic Sciences0 sites0 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Phase 1
- Status
- Not yet recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •Patients more than 18 years of age with moderate to severe dry eye disease
- •Tear film breakup time less than or equal to seven seconds
- •Schirmers test less than or equal to 10mm for 5 min
- •OSDI Score more than equal to 13
Exclusion Criteria
- •Patients not consenting to follow up
- •Presence of active systemic or ocular infection
- •Allergic to any topical eye drops
- •Use of contact lens within last two weeks
- •Pregnant or lactating
- •Associated ocular inflammatory conditions
- •Any cognitive or psychiatric deficit that precludes consent or ability to perform
- •Hace active drug or alcohol dependance
Investigators
Similar Trials
Completed
Phase 3
CITOPROT-IIIDiabetic foot ulcer.Foot UlcerLeg UlcerSkin UlcerDiabetic AngiopathiesVascular DiseasesDiabetes ComplicationsDiabetic NeuropathiesEndocrine System DiseasesCardiovascular DiseasesDiabetes MellitusDiabetic FootRPCEC00000060Center for Genetic Engineering and Biothecnology (CIGB), Havana.147
Completed
Not Applicable
Intradermal naked DNA vaccination for mounting tumor-specific immunity in stage IV melanoma patients: a phase I clinical study10027476melanomaskin cancerNL-OMON35508KI-AV15
Recruiting
Phase 2
Dendritic cell therapy based on nepantigen-gene analysisJPRN-jRCTc030210026Tanigawa Keishi30
Completed
Phase 1
Intratumoral phIL12 GETBasal Cell CarcinomaNCT05077033Institute of Oncology Ljubljana9
Active, not recruiting
Not Applicable
Antiangiogeneettinen hoito lapsipotilailla, joilla on pahanlaatuinen kasvaiPediatric malignancies with no conventional treatment modalities leftEUCTR2008-006989-28-FIHUCH, Hospital for Children and Adolescents
